This website uses cookies to enhance the user experience.
ONCOINVENT ASA

ONCOINVENT ASA995 764 458

Research
Public limited company
Gullhaugveien 7 0484 OSLO, Norge

ONCOINVENT ASA

Home - Oncoinvent
Committed to developing new innovative radiopharmaceutical products for better treatment options for cancer patients Watch company presentation, or download (.pdf) Latest news and press releases ALL202420232022202120202019201820172016 15. May. 2024 Oncoinvent to Present at Cantor Fitzgerald Frontiers in Radiopharma Virtual Summit 2. Apr. 2024 Oncoinvent Announces Changes to its Board of Directors and Formation of Scientific ... Read more

Keywords

researchdevelopment worknatural sciencesengineeringtechnologymedicineagricultureinterdisciplinary research

Links

Organization

CEO
Chairman of the board
Years since formation
14 years
since Aug 11, 2010
Type
Public limited company
VAT registered
Yes
Number of employees
47

Ownership

Number of shares and share classes
19,394,295
1 share class
Total number of shareholders
445
168 companies, 277 persons

Financials

Total operating income 2023
5,790,000
NOK
Annual total result 2023
-143,621,000
NOK
Total equity 2023
54,931,000
NOK
Last update: Oct 14, 2024

Management

Management / administration

NameRoleShares
Managing Director/CEO-

Board

NameRoleShares
Board Member-
Chairman-
Board Member-
Board Member-
Board Member-
Board Member-
Observer-

Others

NameRoleShares
E
ERNST & YOUNG AS
Auditor-

Top 10 individual shareholders

NameRoleShares
-
20.08 %
directly 3.5 %
indirectly 16.59 %
-
3.26 %
indirectly
-
2.95 %
indirectly
-
2.27 %
directly 1.75 %
indirectly 0.52 %
-
2.06 %
indirectly
-
1.99 %
indirectly
-
1.99 %
indirectly
-
1.56 %
indirectly
-
1.52 %
indirectly
-
1.43 %
directly
Last update: Sep 5, 2024

Ownership

Company shareholders

NameShare classNumber of sharesShare
S
SCIENCONS AS
NO0010779341
3,217,223
16.59 %
NO0010779341
1,771,076
9.13 %
H
HADEAN CAPITAL I AS
NO0010779341
919,772
4.74 %
M
MUST INVEST AS
NO0010779341
786,230
4.05 %
C
CANICA AS
NO0010779341
762,530
3.93 %
NO0010779341
690,110
3.56 %
NO0010779341
678,000
3.5 %
B
BLAAHAUGEN AS
NO0010779341
632,500
3.26 %
H
HELENE SUNDT AS
NO0010779341
546,145
2.82 %
B
BENTAX AS
NO0010779341
450,000
2.32 %
NO0010779341
427,151
2.2 %
S
Syntax AS
NO0010779341
400,000
2.06 %
NO0010779341
340,250
1.75 %
NO0010779341
277,600
1.43 %
C
CGS HOLDING AS
NO0010779341
276,915
1.43 %
NO0010779341
261,250
1.35 %
A
ALPINE CAPITAL AS
NO0010779341
235,200
1.21 %
L
LUCELLUM AS
NO0010779341
215,000
1.11 %
I
INVEN2 AS
NO0010779341
210,261
1.08 %
W
WATRIUM AS
NO0010779341
206,923
1.07 %
M
MP PENSJON PK
NO0010779341
186,706
0.96 %
V
VICAMA AS
NO0010779341
160,000
0.82 %
P
PECUNIA FORVALTNING AS
NO0010779341
160,000
0.82 %
R
RH INDUSTRI AS
NO0010779341
136,720
0.7 %
O
OM HOLDING AS
NO0010779341
134,000
0.69 %
NO0010779341
132,148
0.68 %
N
Nordisk Trading AS
NO0010779341
131,000
0.68 %
NO0010779341
120,000
0.62 %
J
JANDERSEN KAPITAL AS
NO0010779341
111,440
0.57 %
NO0010779341
107,000
0.55 %
A
ARVO INVEST AS
NO0010779341
105,000
0.54 %
T
TROLA AS
NO0010779341
100,000
0.52 %
M
MYRLID AS
NO0010779341
96,160
0.5 %
F
FARVATN VENTURE AS
NO0010779341
96,153
0.5 %
H
HARTVIG WENNBERG AS
NO0010779341
76,635
0.4 %
G
GC RIEBER FORTUNA AS
NO0010779341
75,000
0.39 %
NO0010779341
74,631
0.38 %
M
MALMAG CAPITAL AS
NO0010779341
70,000
0.36 %
M
MH CAPITAL AS
NO0010779341
65,000
0.34 %
C
CATILINA INVEST AS
NO0010779341
63,300
0.33 %
A
ADVENTURE-BOOKING NORWAY AS
NO0010779341
61,000
0.31 %
P
PETROSERVICE AS
NO0010779341
60,000
0.31 %
NO0010779341
58,850
0.3 %
N
NORDA ASA
NO0010779341
57,692
0.3 %
B
BLABLA AS
NO0010779341
53,000
0.27 %
NO0010779341
50,000
0.26 %
D
DRØBAK INVEST AS
NO0010779341
50,000
0.26 %
M
MUTUS AS
NO0010779341
50,000
0.26 %
H
HAUSTA VEKST AS
NO0010779341
50,000
0.26 %
M
MYNA AS
NO0010779341
48,189
0.25 %
NO0010779341
46,000
0.24 %
G
GEC HOLDING AS
NO0010779341
45,000
0.23 %
S
SKOG INVEST AS
NO0010779341
45,000
0.23 %
NO0010779341
43,517
0.22 %
L
LANGE INVESTERINGER AS
NO0010779341
40,500
0.21 %
W
WALLCROSS AS
NO0010779341
40,000
0.21 %
H
HILS AS
NO0010779341
40,000
0.21 %
NO0010779341
39,290
0.2 %
NO0010779341
38,800
0.2 %
NO0010779341
38,700
0.2 %
NO0010779341
36,300
0.19 %
E
EWIX AS
NO0010779341
36,000
0.19 %
B
BASEN KAPITAL AS
NO0010779341
33,988
0.18 %
O
OPTIMUSPISTOR AS
NO0010779341
33,650
0.17 %
R
RO INVEST AS
NO0010779341
33,000
0.17 %
L
LBM INVEST AS
NO0010779341
32,500
0.17 %
H
HØVIK FINANS AS
NO0010779341
32,500
0.17 %
Å
ÅSTVEIT INVESTOR AS
NO0010779341
30,000
0.15 %
NO0010779341
29,750
0.15 %
NO0010779341
29,300
0.15 %
NO0010779341
28,528
0.15 %
T
TEAKAY INVEST AS
NO0010779341
27,900
0.14 %
B
BÅTSTØ BRUG AS
NO0010779341
27,896
0.14 %
J
JOMANI AS
NO0010779341
27,000
0.14 %
F
FAST-SPORTS AS
NO0010779341
26,515
0.14 %
NO0010779341
26,500
0.14 %
J
JEEKS AS
NO0010779341
26,000
0.13 %
NO0010779341
25,500
0.13 %
NO0010779341
25,400
0.13 %
B
BYENS MARKER INVEST AS
NO0010779341
25,000
0.13 %
NO0010779341
25,000
0.13 %
P
PIV INVEST AS
NO0010779341
25,000
0.13 %
NO0010779341
24,800
0.13 %
N
NIAN AS
NO0010779341
23,500
0.12 %
NO0010779341
23,300
0.12 %
S
SAVEPIG AS
NO0010779341
23,300
0.12 %
NO0010779341
23,134
0.12 %
NO0010779341
22,300
0.11 %
NO0010779341
21,550
0.11 %
NO0010779341
20,930
0.11 %
A
AUGUST RINGVOLD AGENTUR AS
NO0010779341
20,000
0.1 %
A
AS FINANSPLAN
NO0010779341
20,000
0.1 %
NO0010779341
20,000
0.1 %
M
MARIKOVE INDUSTRIER AS
NO0010779341
20,000
0.1 %
I
IFG HOLDING AS
NO0010779341
20,000
0.1 %
E
EKORNHUSET AS
NO0010779341
20,000
0.1 %
B
BIRK VENTURE AS
NO0010779341
20,000
0.1 %
K
KRISTIAN FALNES AS
NO0010779341
20,000
0.1 %
H
HERBRANDSEN INVEST AS
NO0010779341
20,000
0.1 %
T
TETRAO AS
NO0010779341
20,000
0.1 %
Last update: May 24, 2024

Financials

in NOK

Summary

Year202320222021
Total operating income
5,790,000
6,282,500
11,083,018
Annual Total Result
-143,621,000
-103,756,765
-80,288,555
Total assets
98,734,000
222,244,881
317,620,406
Total liabilities
43,803,000
26,573,144
18,439,580
Total equity
54,931,000
195,671,737
299,180,826

P&L

Year202320222021
Total operating income
5,790,000
6,282,500
11,083,018
Total operating costs
153,215,000
114,370,066
91,925,009
Operating result
-147,425,000
-108,087,566
-80,841,991
Financial income/costs
3,804,000
4,330,801
553,436
Profit before tax
-143,621,000
-103,756,765
-80,288,555
Total tax & extraordinary income/cost
0
0
0
Annual Total Result
-143,621,000
-103,756,765
-80,288,555

Balance overview

Year202320222021
Total fixed assets
40,810,000
9,532,261
10,335,350
Total current assets
57,924,000
212,712,620
307,285,056
Total assets
98,734,000
222,244,881
317,620,406
Short term debt
35,456,000
26,573,144
18,439,580
Long term debt
8,347,000
0
0
Total liabilities
43,803,000
26,573,144
18,439,580
Contributed capital
551,491,000
539,587,150
539,339,469
Retained earnings
-496,560,000
-343,915,413
-240,158,643
Total equity
54,931,000
195,671,737
299,180,826
Total equity and liabilities
98,734,000
222,244,881
317,620,406

Classification

Category
Type of organization
Public limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
M
Main industrial area
Professional, scientific and technical activities
72
Activity
Scientific research and development
72.1
Main industrial group
Research and experimental development on natural sciences and engineering
72.19
Industrial group
Other research and experimental development on natural sciences and engineering
72.190
Industrial group
Other research and experimental development on natural sciences and engineering